M Y Levy, MD

Director of Hematologic Malignancies Research
Texas Oncology-Baylor Charles A. Sammons Cancer Center

Poster(s):

• (359) Healthcare Resource Utilization in Patients with Primary Immune Thrombocytopenia Treated with Avatrombopag in the United States: REAL-AVA 2.0 Study Results
  Wednesday, October 29, 2025